-
ExxonMobil CEO sees chance of higher oil prices as earnings dip
-
Leclerc on top for Ferrari ahead of Verstappen and Piastri
-
Trump says 'not satisfied' with new Iran proposal
-
After Madonna and Lady Gaga, Shakira set for Rio beach mega-gig
-
Trump says will raise US tariffs on EU cars, trucks to 25%
-
Godon raises game to take Romandie stage and revenge over leader Pogacar
-
Celtic's O'Neill expects no let-up from Hibs despite fans' feelings
-
Pope names former undocumented migrant as US bishop
-
Javelin star Kitaguchi teams up with Czech legend Zelezny
-
Sawe sub-2hr marathon captured 'global imagination' says Coe
-
King Charles gets warm welcome in Bermuda after whirlwind US visit
-
Sinner shines to beat Fils, reach Madrid Open final
-
UK court clears comedy writer of damaging transgender activist's phone
-
Was LIV Golf an expensive failure for Saudis? Not everyone thinks so
-
Coe hails IOC gender testing decision
-
McInnes wants Tynecastle in 'full glory' for Hearts title charge
-
McFarlane says troubled Chelsea still attractive to potential managers
-
Man Utd boss Carrick relishes 'special' Liverpool rivalry
-
Baguettes take centre stage on France's Labour Day
-
Spurs must banish 'loser' mentality despite injury woes, says De Zerbi
-
Arsenal must manage emotions of title race says Arteta
-
Nepal temple celebrates return of stolen Buddha statue
-
US Fed official says rate hikes may be needed if inflation surges
-
Fixture pile-up no excuse for Man City in title race: Guardiola
-
Iran offers new proposal amid stalled US peace talks
-
Gulf countries' plans to bypass Hormuz still far off, experts warn
-
Luis Enrique says 'unique' PSG-Bayern first leg could have gone either way
-
Rebels take key military camp in Mali's north
-
Turkish police fire tear gas, arrest hundreds at Istanbul May Day rallies
-
Lufthansa apologises for lost Oscar after US airport security row
-
French hub monitors Hormuz tensions from afar
-
Flick happy Raphinha back for Barca with title in sight
-
UN troubled by rejected appeal of Cambodian opposition leader
-
Activists on Gaza aid flotilla detained by Israel disembark in Crete
-
Oil steady after wild swing, stocks diverge in thin trading
-
Lufthansa says searching for Oscar lost after US airport security row
-
Howe says Saudi backers are fully behind Newcastle
-
Chinese swimmer Sun Yang reports cyberbullying to police
-
Solomon Islands leader to face no-confidence vote after appeal court loss
-
Salah 'deserves big send-off', says Liverpool boss Slot
-
UK police charge man with stabbing attack on two Jewish Londoners
-
Solomon Islands leader loses court appeal, must face no confidence vote
-
Former world skating champion Uno joins pro eSports team
-
Japan baseball umpire hit by bat still unconscious two weeks on
-
Nakatani says won't be intimidated in sold-out Inoue title clash
-
T-Wolves eliminate Nuggets as Knicks demolish Hawks in NBA playoffs
-
Timberwolves eliminate Jokic's Nuggets from NBA playoffs
-
Arsenal seek to ramp up heat on Man City in title race
-
PSG closing in on another French title before Bayern second leg
-
Espanyol must stop rot against Real Madrid as Barca eye title
Trump announces drug prices cut with swipe at Europe
US President Donald Trump said Monday he would slash drug prices so that they match costs abroad, accusing the "brutal" European Union in particular of forcing pharmaceutical firms to lower prices on its turf.
Trump claimed as he signed the executive order at the White House that drug prices should fall by at least 59 percent -- and in some cases as high as 80 or 90 percent.
Under the plan, Trump aims to institute a "Most Favored Nation" policy that pins the cost of drugs sold in the United States to the lowest price paid by other countries for the same drug.
"Whoever is paying the lowest price, that's the price that we're going to get," Trump said.
The US president's plan will count mainly on the goodwill of pharmaceutical companies to negotiate their prices and could face legal challenges, as did a similar proposal Trump pushed during his first term.
Trump said American consumers had been treated like "suckers" and cited in particular the costs of the obesity-reducing drug Ozempic, which he said were vastly higher in Europe.
He blasted the European Union nation in particular over drug prices, alleging that the 27-nation bloc forced pharmaceutical firms to lower their costs on their territory.
"It was really the countries that forced Big Pharma to do things that, frankly, I'm not sure they really felt comfortable doing, but they've gotten away with it," Trump said.
"The European Union has been brutal, brutal. And the drug companies actually told me stories it was just brutal, how they forced them."
- 'Powerful lobby' -
Trump said he would also order an investigation into countries that "extort" drug companies by "blocking their products" unless they accepted low prices.
But Trump added that he was also "doing this against the most powerful lobby in the world -- the drug and pharmaceutical lobby."
Health Secretary Robert Kennedy Jr, who has caused controversy for his skepticism over vaccinations, praised the plan.
"There has never been a president more willing to stand up to the oligarchs than Donald Trump," Kennedy said as he stood next to the billionaire property developer.
Trump had trailed the announcement of the 59 percent cut earlier on Monday.
"DRUG PRICES TO BE CUT BY 59%, PLUS! Gasoline, Energy, Groceries, and all other costs, DOWN. NO INFLATION!!!" Trump posted on his Truth Social platform.
The reduction in prescription drug costs in the United States would, he added in his post, be counterbalanced by higher costs in other countries.
"Most favored nation" status is a World Trade Organization rule that aims to prevent discrimination between a country and its trading partners, levelling the playing field for international trade.
This is not the first time that Trump has attempted to lower US drug prices.
During his first 2017-2021 term in office, he announced a similar proposal to cut US drug prices but his plans failed in the face of strong opposition from the pharmaceutical industry.
Last month, the US president signed an executive order aiming to lower crippling drug prices by giving states more leeway to bargain-hunt abroad and improving the process for price negotiations.
T.Germann--VB